Genetic complexity impacts the clinical outcome of follicular lymphoma patients

• María García-Álvarez,
• Sara Alonso-Álvarez,
• Isabel Prieto-Conde,
• Cristina Jiménez,
• M. Eugenia Sarasquete,
• M. Carmen Chillón,
• Alejandro Medina,
• Ana Balanzategui,
• Rebeca Maldonado,
• Alicia Antón,
• Marta Rodríguez,
• Oscar Blanco,
• Luis G. Díaz,
• Pilar Tamayo,
• Pedro Blanco,
• Carmen Esteban,
• Verónica González-Calle,
• Noemí Puig,
• Norma Gutiérrez,
• Alejandro Martín,
• Ramón García-Sanz,
• Marcos González,
• M. Dolores Caballero,
• Miguel Alcoceba

Affiliations

María García-Álvarez

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Sara Alonso-Álvarez

Department of Hematology, Central University Hospital of Asturias (HUCA)

Isabel Prieto-Conde

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Cristina Jiménez

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

M. Eugenia Sarasquete

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

M. Carmen Chillón

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Alejandro Medina

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Ana Balanzategui

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Rebeca Maldonado

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Alicia Antón

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Marta Rodríguez

Department of Pathology, University Hospital of Salamanca (HUS/IBSAL)

Oscar Blanco

Department of Pathology, University Hospital of Salamanca (HUS/IBSAL)

Luis G. Díaz

Department of Nuclear Medicine, University Hospital of Salamanca (HUS/IBSAL)

Pilar Tamayo

Department of Nuclear Medicine, University Hospital of Salamanca (HUS/IBSAL)

Pedro Blanco

Department of Otorhinolaryngology, University Hospital of Salamanca (HUS/IBSAL)

Carmen Esteban

Department of General and Gastrointestinal Surgery, University Hospital of Salamanca (HUS/IBSAL)

Verónica González-Calle

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Noemí Puig

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Norma Gutiérrez

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Alejandro Martín

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Ramón García-Sanz

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Marcos González

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

M. Dolores Caballero

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Miguel Alcoceba

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)